224060.KQ Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
00:20
May 28
May 28
DND Pharmatech trial catalyst
DND Pharmatech surged on positive MASH (metabolic fatty liver) phase 1 trial results. The pipeline is worth 2-5 trillion won, and successful licensing could propel the stock much higher.
HIGH
About 224060.KQ Analyst Coverage
Buzzberg tracks 224060.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.